Buys
Open market- Shares
- Avg price
- Total value
Scott M. Giacobello - CHIEF FINANCIAL OFFICER at Whitehawk Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- WHWK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Scott M. Giacobello in Whitehawk Therapeutics, Inc.
Sells
Open market- Shares
- -221,194
- Avg price
- $4.03
- Total value
- -$890,613
Net
Past year- Shares
- -221,194
- Share %
- -100%
- Total value
- -$890,613
Reported holdings for Scott M. Giacobello in Whitehawk Therapeutics, Inc.
Form 4 holding
CHIEF FINANCIAL OFFICER
Whitehawk Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 333,489
- Estimated value
- $1,150,537
- Report date
- 14 May 2026
- Price
- $3.45
- Ownership
- Direct
Form 4 holding
CHIEF FINANCIAL OFFICER
Whitehawk Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $1,137,365
- Report date
- 01 Apr 2026
- Price
- $2.40
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
CHIEF FINANCIAL OFFICER
Whitehawk Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 300,677
- Estimated value
- Report date
- 01 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Scott M. Giacobello in Whitehawk Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.